Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Nancy J. Wysenski
Age : 62
Public asset : 687,199 USD
Linked companies : Alkermes plc - Cytokinetics, Incorporated - Provention Bio, Inc.
Nancy J. Wysenski founded EMD Pharmaceuticals, Inc. Ms. Wysenski is on the board of Alkermes, Inc., Cytokinetics, Inc., Alkermes Plc and Provention Bio, Inc. and President-Research Triangle Park Chapter at Healthcare Businesswomens Association.

In her past career she occupied the position of Chief Commercial Officer & Executive VP for Vertex Pharmaceuticals, Inc., President & Chief Executive Officer at EMD Pharmaceuticals, Inc., Chief Operating Officer for Indevus Pharmaceuticals, Inc., Chief Operating Officer at Endo Health Solutions, Inc., Senior Vice President-Operations of NetGenics, Inc., Chief Operating Officer for Endo Pharmaceuticals, Inc. and Vice President-Field Sales at Astra Merck, Inc.

She received an undergraduate degree from Kent State University (Ohio) and an MBA from Baldwin-Wallace College.

Current positions of Nancy J. Wysenski 
NameTitle Since
Alkermes plc
(Biotechnology & Medical Research)
Independent Director 2013
Cytokinetics, Incorporated
(Biotechnology & Medical Research)
Independent Director 2020
Provention Bio, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Alkermes, Inc. Director 2013
Healthcare Businesswomens Association President-Research Triangle Park Chapter -

Holdings of Nancy J. Wysenski 
Alkermes plc (ALKS)
(Biotechnology & Medical Research)
15,9420.0099%498,347 USD
Cytokinetics, Incorporated (CYTK)
(Biotechnology & Medical Research)
5,7280.0069%188,852 USD
Provention Bio, Inc. (PRVB)
(Biotechnology & Medical Research)
00.0000%0 USD

Nancy J. Wysenski: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
More news

© 2021 People and Ownership :   
Nancy J. Wysenski : Connections